Skip to main content

Table 1 List of primers used to amplify the PREPL-C2ORF34 bidirectional promoter fragments

From: Cooperation between NRF-2 and YY-1 transcription factors is essential for triggering the expression of the PREPL-C2ORF34 bidirectional gene pair

Constructs*

Primer sequence

C2ORF34

(Forward)

(Reverse)

+335/-718

5'-GAAGATCTGAATGCAACAGGGAG-3'

5'-GAAGCTTCGCAGGTGGCTCCCGG-3'

-11/-718

5'-AGATCTAGCACGAGCAACAGGCAGAT-3'

5'-GAAGCTTCGCAGGTGGCTCCCGG-3'

-203/-718

5'-AGATCTGGTCCGCCCTCACTCAAGAT-3'

5'-GAAGCTTCGCAGGTGGCTCCCGG-3'

-420/-718

5'-AGATCTCGGGTGTGGAAGGCTCCAGTGAGAT-3'

5'-GAAGCTTCGCAGGTGGCTCCCGG-3'

-580/-718

5'-AGATCTGGTAAGGGAGAACCTGCTCG-3'

5'-GAAGCTTCGCAGGTGGCTCCCGG-3'

-203/-445

5'-AGATCTGGTCCGCCCTCACTCAAGAT-3'

5'-AAGCTTATCTCACTGGAGCCTTCCACACCCG-3'

-262/-445

5'-AGATCTTCGGCCCTGGTTGCCAAGGAGAT-3'

5'-AAGCTTATCTCACTGGAGCCTTCCACACCCG-3'

-203/-385

5'-AGATCTGGTCCGCCCTCACTCAAGAT-3'

5'-AAGCTTCCTGCCAACTTCTTCCCTGT-3'

-203/-345

5'-AGATCTGGTCCGCCCTCACTCAAGAT-3'

5'-AAGCTTACCCTCCCTCCACCGGACCA-3'

PREPL

(Forward)

(Reverse)

-718/+335

5'-AGATCTTCGCAGGTGGCTCCCGGC-3'

5'-AAGCTTGATCTGAATGCAACAGGGAG-3'

-600/+335

5'-AGATCTCGAGCAGGTTCTCCCTTACC-3'

5'-AAGCTTGATCTGAATGCAACAGGGAG-3'

-445/+335

5'-AGATCTCACTGGAGCCTTCCACACCCG-3'

5'-AAGCTTGATCTGAATGCAACAGGGAG-3'

-225/+335

5'-AGATCTTGAGTGAGGGCGGACCAGA-3'

5'-AAGCTTGATCTGAATGCAACAGGGAG-3'

-33/+335

5'-AGATCTGCCTGTTGCTCGTGCTAGA-3'

5'-AAGCTTGATCTGAATGCAACAGGGAG-3'

-445/-203

5'-GAAAGATCTCACTGGAGCCTTCCACACCCG-3'

5'-AAGCTTCTGGTCCGCCCTCACTCAAGAT-3'

-445/-262

5'-GAAAGATCTCACTGGAGCCTTCCACACCCG-3'

5'-AAGCTTCGGCCCTGGTTGCCAAGGAGAT-3'

-385/-203

5'-AGATCTCCTGCCAACTTCTTCCCTGT-3'

5'-AAGCTTCTGGTCCGCCCTCACTCAAGAT-3'

-345/-203

5'-AGATCTACCCTCCCTCCACCGGACCA-3

5'-AAGCTTCTGGTCCGCCCTCACTCAAGAT-3'

  1. *All construct names refer to the positions of nucleotides, counting from the first to the last nucleotide of the inserted genomic DNA sequences. The inserted fragments were first amplified by PCR using a series of forward primers with a BglII site (5'-AGATCT) and reversed primers with a HindIII site (5'-AAGCTT). Each amplified fragment was then digested with two restriction enzymes and cloned into the pGL3-Basic vector (Promega).